The polysaccharide capsule of Campylobacter jejuni modulates the host immune response

Infection and Immunity

Volumn 81, Issue 3, 2013, Pages 665-672

  Maue, Alexander C ^a   Mohawk, Krystle L ^a   Giles, David K ^b   Poly, Frédéric ^a   Ewing, Cheryl P ^a   Jiao, Yuening ^c   Lee, Ginyoung ^c   Ma, Zuchao ^c   Monteiro, Mario A ^c   Hill, Christina L ^a   Ferderber, Jason S ^a   Porter, Chad K ^a   Trent, Stephen M ^d   Guerry, Patricia ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF TENNESSEE AT CHATTANOOGA   (United States)

^c UNIVERSITY OF GUELPH   (Canada)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CAPSULE; BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; BACTERIUM MUTANT; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CD4+ T LYMPHOCYTE; CHEMICAL MODIFICATION; COLONY FORMING UNIT; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOMODULATION; LAMINA PROPRIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CYTOKINES; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MICE; MUTATION; NF-KAPPA B; POLYSACCHARIDES, BACTERIAL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84874681098     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01008-12     Document Type: Article

References (58)

1. Bacon DJ, Szymanski CM, Burr DH, Silver RP, Alm RA, Guerry P. 2001. A phase variable capsule is involved in virulence of Campylobacter jejuni 81-176. Mol. Microbiol. 40:769-777.
2. Champion OL, Karlyshev AV, Senior NJ, Woodward M, La Ragione R, Howard SL, Wren BW, Titball RW. 2010. Insect infection model for Campylobacter jejuni reveals that O-methyl phosphoramidate has insecticidal activity. J. Infect. Dis. 201:776-782.
3. Rose A, Kay E, Wren BW, Dallman MJ. 2012. The Campylobacter jejuni NCTC 11168 capsule prevents excessive cytokine production by dendritic cells. Med. Microbiol. Immunol. 201:137-144.
4. Karlyshev AV, Linton D, Gregson NA, Lastovica AJ, Wren BW. 2000. Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity. Mol. Microbiol. 35:529-541.
5. Guerry P, Szymanski CM. 2008. Campylobacter sugars sticking out. Trends Microbiol. 16:428-435.
6. Karlyshev AV, Champion OL, Churcher C, Brisson J-R, Jarrell HC, Gilbert M, Brochu D, St Michael F, Li J, Wakarchuk WW, Goodhead I, Sanders M, Stevens K, White B, Parkhill J, Wren BW, Szymanski CM. 2005. Analysis of Campylobacter jejuni capsular loci reveals multiple mechanisms for the generation of structural diversity and the ability to form heptoses. Mol. Microbiol. 55:90-103.
7. Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, Chillingworth T, Davies RM, Feltwell T, Holroyd S, Jagels K, Karlyshev AV, Moule S, Pallen MJ, Penn CW, Quail MA, Rajandream MA, Rutherford KM, van Vliet AHM, Whitehead S, Barrell BG. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable tracts. Nature 403:665-668.
8. McNally DJ, Lamoureux MP, Karlyshev AV, Fiori LM, Li J, Thacker G, Coleman RA, Khieu NH, Wren BW, Brisson JR, Jarrell HC, Szymanski CM. 2007. Commonality and biosynthesis of the O-methyl phosphoramidate capsule modification in Campylobacter jejuni. J. Biol. Chem. 282: 28566-28576.
9. Monteiro MA, Baqar S, Hall ER, Chen Y-H, Porter CK, Bentzel DE, Applebee L, Guerry P. 2009. A capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni. Infect. Immun. 77:1128-1136.
10. Ewing CP, Andreishcheva E, Guerry P. 2009. Functional characterization of flagellin glycosylation in Campylobacter jejuni 81-176. J. Bacteriol. 191:7086-7093.
11. Guerry P, Ewing CP, Hickey TE, Prendergast MM, Moran AP. 2000. Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni. Infect. Immun. 68:6656-6662.
12. Kanipes MI, Tan X, Akelaitis A, Li J, Rockabrand D, Guerry P, Monteiro MA. 2008. Genetic analysis of lipooligosaccharide core biosynthesis in Campylobacter jejuni 81-176. J. Bacteriol. 190:1568-1574.
13. Yao R, Alm RA, Trust TJ, Guerry P. 1993. Construction of new Campylobacter cloning vectors and a new mutational cat cassette. Gene 130: 127-130.
14. Guerry P, Ewing CP, Schirm M, Lorenzo M, Kelly J, Pattarini D, Majam G, Thibault P, Logan SM. 2006. Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence. Mol. Microbiol. 60:299-311.
15. Institute of Laboratory Animals Resources, National Research Council. 1966. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
16. Lefrançois L, Lycke N. 2001. Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer's patch and lamina propria cells. Curr. Protoc. Immunol. 17:3.19.1-3.19.16. doi:10.1002/0471142735.im0319s17.
17. Keo T, Collins J, Kunwar P, Blaser MJ, Iovine NM. 2011. Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials. Virulence 2:30-40.
18. Berndtson E, Danielsson-Tham ML, Engvall A. 1994. Experimental colonization of mice with Campylobacter jejuni. Vet. Microbiol. 41:183-188.
19. Blaser MJ, Duncan DJ, Warren GH, Wang WLL. 1983. Experimental Campylobacter jejuni infection of adult mice. Infect. Immun. 39:908-916.
20. Fox JG. 1992. In vivo models of enteric campylobacteriosis: natural and experimental infections, p 131-138. In Nachamkin I, M. J. Blaser MJ, Tompkins LS (ed), Campylobacter jejuni: current status and future trends. American Society for Microbiology, Washington, DC.
21. Hodgson AE, McBride BW, Hudson MJ, Hall G, Leach S. 1998. Experimental campylobacter infection and diarrhoea in immunodeficient mice. J. Med. Microbiol. 47:799-809.
22. Mansfield LS, Bell JA, Wilson DL, Murphy AJ, Elsheikha HM, Rathinam VAK, Fierro BR, Linz JE, Young VB. 2007. C57BL/6 and congenic interleukin-10-deficient mice can serve as models of Campylobacter jejuni colonization and enteritis. Infect. Immun. 75:1099-1115.
23. Naito M, Frirdich E, Fields JA, Pryjma M, Li J, Cameron A, Gilbert M, Thompson SA, Gaynor EC. 2010. Effects of sequential Campylobacter jejuni 81-176 lipooligosaccharide core truncations on biofilm formation, stress survival and pathogenesis. J. Bacteriol. 192:182-192.
24. Watson RO, Novik V, Hofreuter D, Lara-Tejero M, Galan JE. 2007. A MyD88-deficient mouse model reveals a role for Nramp1 in Campylobacter jejuni infection. Infect. Immun. 75:1994-2003.
25. Bachtiar BM, Coloe PJ, Fry BN. 2007. Knockout mutagenesis of the kpsE gene of Campylobacter jejuni 81116 and its involvement in bacterium-host interactions. FEMS Immunol. Med. Microbiol. 49:149-154.
26. Grant AJ, Coward C, Jones MA, Woodall CA, Barrow PA, Maskell DJ. 2005. Signature-tagged transposon mutagenesis studies demonstrate the dynamic nature of cecal colonization of 2-week old chickens by Campylobacter jejuni. Appl. Environ. Microbiol. 71:8031-8041.
27. Hooper LV, Littman DR, Macpherson AJ. 2012. Interactions between the microbiota and the immune system. Science 336:1268-1273.
28. Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, Kunisawa J, Shibata N, Grunberg S, Sinha R, Zahm AM, Tardif MR, Sathaliyawala T, Kubota M, Farber DL, Collman RG, Shaked A, Fouser LA, Weiner DB, Tessier PA, Friedman JR, Kiyono H, Bushman FD, Chang KM, Artis D. 2012. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336: 1321-1325.
29. Geddes K, Rubino SJ, Magalhaes JG, Streutker C, LeBourhis L, Cho JH, Robertson SJ, Kim CJ, Kaul R, Philpott DJ, Girardin SE. 2011. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat. Med. 17:837-844.
30. Mayuzumi H, Inagaki-Ohara K, Uyttenhouve C, Okamoto Y, Matsuzaki G. 2010. Interleukin 17-A is required to suppress invasion of Salmonella enterica serovar Typhimurium to enteric mucosa. Immunology 131: 377-385.
31. Song X, Zhu S, Shi P, Liu Y, Shi Y, Levin SD, Qian Y. 2011. IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat. Immunol. 12:1151-1158.
32. Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, Bridonneau C, Rochet V, Pisi A, De Paepe M, Brandi G, Eberl G, Snel J, Kelly D, Cerf-Bensussan N. 2009. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31:677-689.
33. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485-498.
34. Rubino SJ, Geddes K, Girardin SE. 2012. Innate IL-17 and IL-22 responses to enteric bacterial pathogens. Trends Immunol. 33:112-118.
35. Korn T, Bettelli E, Oukka M, Kuchroo VK. 2009. IL-17 and Th17 cells. Annu. Rev. Immunol. 27:485-517.
36. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203:2271-2279.
37. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14:282-289.
38. Edwards LA, Nistala K, Mills DC, Stephenson HN, Zilbauer M, Wren BW, Dorrell N, Lindley KJ, Wedderburn LR, Bajaj-Elliott M. 2010. Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection. PLoS One 5:e15398. doi:10.1371/journal.pone.0015398.
39. Dongari-Bagtzoglou AI, Ebersole JL. 1996. Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J. Periodontal Res. 31:90-98.
40. Raffatellu M, Chessa D, Wilson RP, Tukel C, Akcelik M, Baumler AJ. 2006. Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis. Infect. Immun. 74:19-27.
41. Raffatellu M, Chessa D, Wilson RP, Dusold R, Rubino S, Baumler AJ. 2005. The Vi capsular antigen of Salmonella enterica serotype typhi reduces Toll-like receptor-dependent interleukin-8 expression in the intestinal mucosa. Infect. Immun. 73:3367-3374.
42. Raffatellu M, Santos RL, Chessa D, Wilson RP, Winter SE, Rossetti CA, Lawhon SD, Chu H, Lau T, Bevins CL, Adams LG, Baumler AJ. 2007. The capsule encoding the viaB locus reduces interleukin-17 expression and mucosal innate responses in the bovine intestinal mucosa during infection with Salmonella enterica serotype Typhi. Infect. Immun. 75:4342-4350.
43. Sharma A, Qadri A. 2004. Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. Proc. Natl. Acad. Sci. U. S. A. 101: 17492-17497.
44. Unkmeir A, Kammerer U, Stade A, Hubner C, Haller S, Kolb-Maurer A, Frosch M, Dietrich G. 2002. Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells. Infect. Immun. 70:2454-2462.
45. Kocabas C, Katsenelson N, Kanswai S, Kennedy MN, Cui X, Blake MS, Segal DM, Akkoyuniu M. 2007. Neisseria meningitidis type C capsular polysaccharide inhibits lipooliogosaccharide-induced cell activation by binding to CD14. Cell. Microbiol. 9:1297-1310.
46. Weiser JN, Pan N, McGowan KL, Musher D, Martin A, Richards J. 1998. Phosphorylcholine on the lipooligosaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med. 187:631-640.
47. Andersen-Nissen E, Smith KD, Strobe KL, Barrett SLR, Cookson BT, Logan SM, Aderem A. 2005. Evasion of toll-like receptor 5 by flagellated bacteria. Proc. Natl. Acad. Sci. U. S. A. 102:9247-9252.
48. Galkin VE, Yu X, Bielnick J, Heuser J, Ewing CP, Guerry P, Egelman EH. 2008. Divergence of quaternary structures among bacterial flagellar filaments. Science 320:382-385.
49. van Mourik A, Steeghs L, van Laar J, Meiring HD, Hamstra H-J, van Putten JPM, Wösten MMSM. 2010. Altered linkage of hydroxyacyl chains in lipid A of Campylobacter jejuni reduces TLR4 activation and antimicrobial resistance. J. Biol. Chem. 285:15828-15836.
50. van Sorge NM, Bleumink NM, van Vliet SJ, Saeland E, van der Pol WL, van Kooyk Y, van Putten JP. 2009. N-glycosylated proteins and distinct lipooligosaccharide glycoforms of Campylobacter jejuni target the human C-type lectin receptor MGL. Cell. Microbiol. 11:1768-1781.
51. Blaser MJ, Glass RI, Huq MI, Stoll B, Kibriay GM, Alim AR. 1980. Isolation of Campylobacter fetus subspecies jejuni from Bangladeshi children. J. Clin. Microbiol. 12:744-777.
52. Pazzaglia G, Bourgeois AL, El Diwany K, Nour N, Badran N, Hablas R. 1991. Campylobacter diarrhoea and an association of recent disease with asymptomatic shedding in Egyptian children. Epidemiol. Infect. 106:77-82.
53. Rajan DP, Mathan VI. 1982. Prevalence of Campylobacter fetus subspecies jejuni in healthy populations in Southern India. J. Clin. Microbiol. 15:749-751.
54. Baqar S, Tribble D, Carmolli M, Sadigh K, Poly F, Porter C, Larsson CJ, Pierce KK, Guerry P, Campylobacter Study Team, Darsley M, Kirkpatrick B. 2010. Recrudescent Campylobacter jejuni infection in an immunocompetent adult following experimental infection with a wellcharacterized organism. Clin. Vaccine Immunol. 17:80-86.
55. Guerry P, Szymanski CM, Prendergast MM, Hickey TE, Ewing CP, Pattarini DL, Moran AP. 2002. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect. Immun. 70:787-793.
56. Hendrixson DR. 2006. A phase-variable mechanism controlling the Campylobacter jejuni FlgR response regulator influences commensalism. Mol. Microbiol. 61:1646-1659.
57. Hendrixson DR. 2008. Restoration of flagellar biosynthesis by varied mutational events in Campylobacter jejuni. Mol. Microbiol. 70:519-536.
58. Linton D, Gilbert M, Hitchen PG, Dell A, Morris HR, Wakarchuk WW, Gregson NA, Wren BW. 2000. Phase variation of a β-1,3 galactosyltransferase involved in generation of the gangliosideGM1-like lipooligosaccharide of Campylobacter jejuni. Mol. Microbiol. 37:501-514. Maue et al. 672.